STOCK TITAN

CORP (BCPC) director awarded 870 restricted shares at $0

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CORP director David B. Fischer reported an acquisition of common stock through a restricted stock award. On February 11, 2026, he received 870 shares at a price of $0, characterized as a grant or award. These restricted shares vest in one year under a Restricted Stock Grant Agreement with the company. Following this transaction, Fischer directly holds 8,859 shares of CORP common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fischer David B

(Last) (First) (Middle)
C/O BALCHEM CORPORATION
5 PARAGON DRIVE

(Street)
MONTVALE NJ 07645

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/11/2026 A 870(1) A $0 8,859 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
/s/ Travis Larsen, Attorney in Fact for David B Fischer 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CORP (BCPC) report for David B. Fischer?

CORP director David B. Fischer reported acquiring 870 shares of common stock through a restricted stock grant on February 11, 2026, at a price of $0 per share. This award increased his direct holdings to 8,859 CORP shares.

Was the CORP (BCPC) insider transaction a purchase or an award?

The CORP transaction was an award, not an open-market purchase. The Form 4 lists transaction code “A,” described as a grant, award, or other acquisition, with 870 restricted shares received at $0 per share under a Restricted Stock Grant Agreement.

How many CORP (BCPC) shares does David B. Fischer own after the grant?

After receiving the 870-share restricted stock grant, David B. Fischer directly owns 8,859 CORP common shares. This figure reflects his beneficial ownership following the February 11, 2026 transaction reported on the Form 4 filing.

When do David B. Fischer’s CORP (BCPC) restricted shares vest?

The 870 restricted CORP shares granted to David B. Fischer vest one year after the grant date. Vesting and transfer are governed by the Restricted Stock Grant Agreement between CORP and Fischer, which imposes transfer restrictions during the vesting period.

What role does David B. Fischer hold at CORP (BCPC) in this Form 4?

In this Form 4, David B. Fischer is identified as a director of CORP. The filing indicates the transaction involves his direct beneficial ownership of common stock, with no officer role or 10% owner status checked in the relationship section.
Balchem Corp

NASDAQ:BCPC

BCPC Rankings

BCPC Latest News

BCPC Latest SEC Filings

BCPC Stock Data

5.86B
32.21M
0.37%
90.95%
1.44%
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE